CONFERENCE INFORMATION

Conference Description

This one-day, high-impact multidisciplinary conference will deliver a cutting-edge update on the latest advances in thoracic oncology, with a focus on the evolving landscape of lung cancer care. Key topics will include:

Innovations in lung cancer screening and interventional pulmonary techniques
The expanding role of social media and artificial intelligence in thoracic oncology practice
Multidisciplinary strategies for managing early-stage, locally advanced, and metastatic non-small cell and small cell lung cancers
Breakthrough therapies, including targeted treatments, immunotherapy, and novel systemic options

Each session will feature expert-led presentations followed by interactive panel discussions, offering attendees ample opportunity to engage directly with faculty during frequent Q&A segments. To further enrich the educational experience, interactive debates and case studies presented by fellows will foster practical, peer-driven learning. Participants will also receive on-demand access to presentation materials for continued review after the event.

Target Audience

This educational activity has been designed to address the learning needs of a diverse oncology care team, including physicians, nurses, nurse practitioners, physician associates, pharmacists, residents, fellows, and other health care professionals involved in the diagnosis, treatment, and management of patients with lung cancer.

Learner Objectives

Upon completion of this activity, participants should be able to:

Summarize the latest evidence and recommendations in lung cancer screening, including advances in early detection methods.
Describe the evolving role of interventional pulmonary procedures in the diagnosis and management of lung cancer.
Evaluate emerging applications of artificial intelligence and social media in improving lung cancer care delivery, education, and patient engagement.
Analyze the multidisciplinary treatment strategies for non-small cell lung cancer (NSCLC), including surgical resection, neoadjuvant/adjuvant therapies, targeted treatments, immunotherapy, and novel systemic therapies.
Discuss current updates in the therapeutic landscape for small cell lung cancer (SCLC), with a focus on integration into clinical practice.